{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:09:29Z","timestamp":1783973369271,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtha.2025.12.030","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:30:04Z","timestamp":1770395404000},"page":"1643-1653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A 25-year evaluation of direct local international normalized ratio calibration of the Owren type prothrombin time method in Sweden"],"prefix":"10.1016","volume":"24","author":[{"given":"Andreas","family":"Hillarp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet Eriksson","family":"Boija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0174-8152","authenticated-orcid":false,"given":"Tomas L.","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.12.030_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000441-193510000-00009","article-title":"A study of the coagulation defect in hemophilia and in jaundice","volume":"190","author":"Quick","year":"1935","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jtha.2025.12.030_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4049\/jimmunol.29.2.87","article-title":"On the relationship between complement and prothrombin","volume":"29","author":"Quick","year":"1935","journal-title":"J Immunol"},{"key":"10.1016\/j.jtha.2025.12.030_bib3","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jtha.2024.05.013","article-title":"The historical origins of modern international normalized ratio targets","volume":"22","author":"Raza","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib4","first-page":"81","article-title":"Expert Committee on Biological Standardisation. Requirements for thromboplastins and plasmas used to control oral anticoagulant therapy. 33rd report","volume":"687","year":"1983","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.jtha.2025.12.030_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/00365515109060600","article-title":"The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin","volume":"3","author":"Owren","year":"1951","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jtha.2025.12.030_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(59)90857-8","article-title":"Thrombotest. A new method for controlling anticoagulant therapy","volume":"2","author":"Owren","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.12.030_bib7","first-page":"1065","article-title":"Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome","volume":"84","author":"Della Valle","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.12.030_bib8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00277-015-2374-3","article-title":"Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome","volume":"94","author":"Isert","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2025.12.030_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2141.2001.03178.x","article-title":"Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins","volume":"115","author":"Tripodi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.12.030_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH10-06-0342","article-title":"Expert Group on Coagulation of the External Quality Assurance in Laboratory Medicine in Sweden. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays","volume":"105","author":"Lindahl","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1538-7836.2010.04098.x","article-title":"Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays","volume":"9","author":"Hillarp","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jth.12649","article-title":"Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays","volume":"12","author":"Hillarp","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/00365513.2018.1522664","article-title":"Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays","volume":"78","author":"Hillarp","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jtha.2025.12.030_bib14","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1515\/cclm-2019-1321","article-title":"Assignment of international normalized ratio to frozen and freeze-dried pooled plasmas","volume":"58","author":"van den Besselaar","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2025.12.030_bib15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1160\/TH03-07-0456","article-title":"INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples","volume":"91","author":"Lindahl","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib16","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1515\/cclm-2017-0976","article-title":"International normalized ratio (INR) testing in Europe: between-laboratory comparability of test results obtained by Quick and Owren reagents","volume":"56","author":"Meijer","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2025.12.030_bib17","first-page":"64","article-title":"Expert Committee on Biological Standardisation. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy","volume":"889","year":"1999","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.jtha.2025.12.030_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00769-006-0107-y","article-title":"Calibration services in the frame of accredited coagulation EQA schemes - meeting the IVD directive","volume":"11","author":"Ornemark","year":"2006","journal-title":"Accred Qual Assur"},{"key":"10.1016\/j.jtha.2025.12.030_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1160\/TH03-07-0419","article-title":"Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme","volume":"91","author":"Hillarp","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2023.07.003","article-title":"Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D","volume":"229","author":"Welander","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.12.030_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11239-020-02319-w","article-title":"Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants","volume":"52","author":"Wallvik","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.12.030_bib23","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/eurheartj\/ehr134","article-title":"Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA","volume":"32","author":"Wieloch","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.12.030_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.thromres.2015.04.016","article-title":"Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden","volume":"136","author":"Bj\u00f6rck","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.12.030_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1055\/s-0035-1544197","article-title":"Bridging the gap between point-of-care testing and laboratory testing in hemostasis","volume":"41","author":"Kitchen","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jtha.2023.01.038","volume":"21","author":"Kitchen","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib28","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1055\/s-0037-1614889","article-title":"Calibration of local systems with lyophilized calibrant plasmas improves the interlaboratory variability of the INR in the Italian external quality assessment scheme","volume":"82","author":"Chantarangkul","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ajcp\/111.2.193","article-title":"Calculation vs calibration curve for INR determination. Results of an interlaboratory proficiency scheme","volume":"111","author":"Brien","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2025.12.030_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ajcp\/108.1.83","article-title":"Long-term French experience in INR standardization by a procedure using plasma calibrants","volume":"108","author":"Houbouyan","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2025.12.030_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0037-1612946","article-title":"Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study","volume":"87","author":"Adcock","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.030_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/aqv022","article-title":"Harmonizing the international normalized ratio (INR): standardization of methods and use of novel strategies to reduce interlaboratory variation and bias","volume":"145","author":"Favaloro","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2025.12.030_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ajcp\/aqae090","article-title":"Continued harmonization of the international normalized ratio across a large laboratory network: evidence of sustained low interlaboratory variation and bias after a change in instrumentation","volume":"163","author":"Favaloro","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtha.2025.12.030_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1515\/cclm-2022-1080","article-title":"Using three external quality assurance schemes to achieve equivalent international normalized ratio results in primary and secondary healthcare","volume":"61","author":"Stavelin","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2025.12.030_bib35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00001721-200210000-00010","article-title":"Has the Quick or the Owren prothrombin time method the advantage in harmonization for the international normalized ratio system?","volume":"13","author":"Horsti","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.12.030_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1515\/CCLM.2002.064","article-title":"Comparison of quick and owren prothrombin time with regard to the harmonisation of the international normalised ratio (INR) system","volume":"40","author":"Horsti","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2025.12.030_bib37","first-page":"176","article-title":"Regulation (EU) 2017\/746 of the European Parliament and of the Council of 5 April 2017","volume":"117","year":"2017","journal-title":"OJEU"},{"key":"10.1016\/j.jtha.2025.12.030_bib38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1515\/cclm-2025-0157","article-title":"Manual tilt tube method for prothrombin time: a commentary on contemporary relevance","volume":"63","author":"Favaloro","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2025.12.030_bib39","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jtha.2023.12.013","volume":"22","author":"van den Besselaar","year":"2024","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:56:34Z","timestamp":1783972594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538783626000528"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.12.030","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 25-year evaluation of direct local international normalized ratio calibration of the Owren type prothrombin time method in Sweden","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}